HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
WorldQuant Foundry Appoints Dr Christopher Mason as Senior Healthcare Advisor to Spearhead AI-Driven Healthcare Innovation
In his new role, Dr. Mason will collaborate with the WorldQuant Foundry ecosystem of entrepreneurs and data scientists in an effort to identify and develop transformative opportunities in the healthcare sector.
Chris Freeman Appointed Strategic Advisor at Cyted Health
“The expertise Chris Freeman brings in leading large-scale commercialization strategies is unparalleled,” said Dr Marcel Gehrung, Cyted Health’s CEO and Co-Founder. “Cyted Health’s transformative technology is already modernising diagnostic pathways across the UK. Chris’ insights will be instrumental as we pursue significant opportunities ahead of us in the US and globally.”
Paul Ziegler Appointed President and CEO of Augmedics
“I am thrilled to join the Augmedics team and build on the foundation they’ve established as the leading spine-based AR platform on the market,” said Paul Ziegler. “I am excited and honored to lead the company through this next phase of growth as we capitalize on the game-changing potential of xvision to make spine surgery safer, simpler, and more reproducible.”
Nusano Names Medical Radioisotopes Advisory Board
“As a radioisotope producer, Nusano plays a critical role in the supply chains of drug developers, healthcare providers and researchers,” said Chris Lowe, CEO of Nusano. “Establishing a Medical Radioisotopes Advisory Board reflects our ongoing commitment to proactively enabling the next generation of oncology research. The board’s guidance will ensure Nusano is providing a stable and scalable supply of isotopes for new areas of research and patient care.”
Jason Whiting Appointed CEO of Avation Medical
Jason Whiting has more than 25 years of experience in the MedTech industry, driving innovation and adoption of new technologies in the implantable, capital equipment, and wearable markets.
Jay Hallinan Appointed Chief Commercial Officer of Q’Apel Medical
Jay Hallinan will lead the company's global sales and marketing organization, oversee Q'Apel's commercial strategy and drive revenue growth across Q'Apel's expanding product portfolio.
Robert Guigley Is Appointed Chief Commercial Officer of DELFI Diagnostics
Robert Guigley most recently served as the Chief Commercial Officer at Invitae, where he orchestrated a commercial reorganization to transition from a growth-centric to a sustainable profit model.
Darrin T Schellin Becomes the New CEO at Pharma Tech Industries
Pharma Tech Industries, a leading global provider of contract manufacturing and packaging solutions for pharmaceutical, medical device, and wellness products, has announced the immediate...
Mark Gaffney Is Appointed CEO of Calluna Pharma | Mark Altmeyer as Independent Chair of the Board
Mark Gaffney brings over 20 years of experience in corporate strategy, business development, and operations in both private and public biotechnology companies, and will lead the team that defines and executes on the corporate strategy, particularly as its lead program is on pace to complete its Phase 1 program later this year.